Spero Therapeutics Inc banner

Spero Therapeutics Inc
NASDAQ:SPRO

Watchlist Manager
Spero Therapeutics Inc Logo
Spero Therapeutics Inc
NASDAQ:SPRO
Watchlist
Price: 2.54 USD -0.39% Market Closed
Market Cap: $147m

Wall St Price Targets

SPRO Price Targets Summary
Spero Therapeutics Inc

Wall Street analysts forecast SPRO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRO is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.

Lowest Forecast
Price Target
4.04 USD
59% Upside
Average Forecast
Price Target
4.08 USD
61% Upside
Highest Forecast
Price Target
4.2 USD
65% Upside
Spero Therapeutics Inc Competitors:
Price Targets
NWSA
News Corp
30% Upside

Revenue
Forecast

80% / Year
Past Growth
-20% / Year
Estimated Growth
Estimates Accuracy
29%
Average Beat
80% / Year
Past Growth
-20% / Year
Estimated Growth
Estimates Accuracy
29%
Average Beat

Over the last 9 years, the compound annual growth rate for Revenue has been 80%. The projected CAGR for the next 3 years is -20%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
129% / Year
Estimated Growth
Estimates Accuracy
-63%
Average Miss
N/A
Past Growth
129% / Year
Estimated Growth
Estimates Accuracy
-63%
Average Miss

The compound annual growth rate for Net Income over the next 2 years is 129%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SPRO's stock price target?
Price Target
4.08 USD

According to Wall Street analysts, the average 1-year price target for SPRO is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.

What is the Revenue forecast for Spero Therapeutics Inc?
Projected CAGR
-20%

Over the last 9 years, the compound annual growth rate for Revenue has been 80%. The projected CAGR for the next 3 years is -20%.

What is the Net Income forecast for Spero Therapeutics Inc?
Projected CAGR
129%

The compound annual growth rate for Net Income over the next 2 years is 129%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett